The COVID-19 pandemic has magnified systemic failures across health care locally and globally—from depleted public health infrastructures, fragmented delivery systems, and unacceptable outcome disparities. Ariadne Labs has been focused on developing evidence-based solutions to support clinicians, patients, the general public, and public health decision-makers. Our COVID-19 response builds on our core strengths—the ability to quickly convene, converge, and gather best ideas and practices; design and test guidelines and tools; and then strategically disseminate them as widely as possible through the many channels available to us.
Focus Areas
Supporting systems to deliver vaccines with speed, scale, and equity as supply and demand shift over time.
LEARN MORE
Focusing on communicating simple, easy to use information for the general public to mitigate the exposure and spread of COVID-19.
LEARN MORE
A global response can aid in ensuring equitable, efficient COVID-19 responses.
LEARN MORE
Innovating around the impacts of COVID-19 on obstetric services from prenatal, labor and delivery, and postnatal care.
LEARN MORE
Resources for patients and providers to offer guidance and best practices to ensure safe, effective outpatient care.
LEARN MORE
Resources to help health systems and providers navigate the impact of COVID-19 to ensure the safety of patients and the health care workforce.
LEARN MORE
Tools and resources for adults over the age of 65 and those with pre-existing health risks who at higher risk of severe illness from COVID-19.
LEARN MOREHighlights
MGB coverage on the International Consortium of Newborn Sequencing (ICoNS) publishing of their findings and tool in Genetics in Medicine. They identified key factors influencing gene inclusion in newborn genomic screening programs and the team developed a machine learning model incorporating 13 predictors, achieving high accuracy in predicting gene selection across programs.
TIME reports on new research co-authored by Dr. Rose Molina and published in JAMA Network Open on April 9, that analyzed four years of nationwide data from the U.S. Centers for Disease Control and Prevention.
Postpartum hemorrhage is the leading cause of maternal death during childbirth. Every year, it affects 14 million women around the world. About 70,000 of those women die as a result, and many more require urgent surgery to control the bleeding. Global guidelines have offered insight into how to effectively manage postpartum hemorrhage in a clinical… Continue reading Combating Postpartum Hemorrhage with Effective Implementation